Simon Winther
VIP, Clinical Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Aims This study aimed to determine the impact of left ventricular mass (LVM) on discordant stress cardiac magnetic resonance (CMR) imaging and invasive coronary angiography (ICA) in patients with suspected coronary artery disease (CAD) at coronary computed tomography angiography (CCTA). Methods and results In this substudy of the Dan-NICAD 2 trial (NCT03481712), 354 patients with suspected obstructive CAD on CCTA were examined with both rest and stress CMR and ICA for invasive physiological measurements. An abnormal stress CMR was defined as ≥2 contiguous segments with a stress perfusion defect, late gadolinium enhancement, or wall motion abnormality. CMR-derived LVM was sex-adjusted by conversion from grams to per cent. Haemodynamically obstructive CAD at ICA was defined as visual diameter stenosis >90% or FFR ≤0.80. LVM was higher in patients with an abnormal stress CMR compared to those with a normal CMR (median difference = 8.0%, P < 0.001). Patients with or without haemodynamically obstructive CAD had similar LVM (median difference = 2%, P = 0.222). Within four binary groups based on normal/abnormal stress CMR and ICA, both median LVM and index of microvascular resistance were higher in patients with discordant abnormal stress CMR and normal ICA than in patients with concordant normal stress CMR and ICA (124% vs. 111%, P = 0.001, and 29 vs. 19, P = 0.072, respectively). Conclusion In patients with suspected obstructive CAD, increased LVM can potentially confound concordance between stress CMR and ICA. This is due to increased microvascular resistance, which decreases the pressure gradient across an epicardial stenosis, resulting in a false high FFR and thus, normal ICA.
Year:
2026
Aims Risk factor-weighted clinical likelihood (RF-CL) estimates the probability of obstructive coronary artery disease (CAD) in patients without known CAD. We examined whether adding lipoprotein(a) [Lp(a)] measurements to the RF-CL model improves predictions of obstructive CAD. Methods and results In a derivation cohort (N = 4262; 54% male; mean age 58 years), the prevalence of obstructive CAD at invasive angiography with fractional flow reserve was assessed by Lp(a)-strata. On the basis of initial results, an Lp(a)-adjusted model (RF-CLLp(a)) was developed: RF-CL was multiplied by 1.5 in patients with elevated Lp(a) (≥125 nmol/L) and otherwise unchanged. Discrimination, calibration, and reclassification were compared. Findings were validated in an external validation cohort (N = 1595; 49% male; mean age 60 years) using a comparative endpoint; significant stenosis at invasive angiography or coronary computed tomography. In the derivation cohort, 473 patients (11.1%) had obstructive CAD; in the validation cohort, 206 patients (12.9%) had significant stenosis. The relative risk in patients with elevated Lp(a) was 1.51 [95% confidence interval (CI) 1.23–1.86] and 1.19 (95% CI 0.88–1.60) in the derivation and validation cohort, respectively. In the derivation cohort, the RF-CLLp(a) model showed a higher area under the receiver operating curve than the RF-CL model [0.743 (standard error 0.011) vs. 0.740 (0.013)] and better calibration in patients with elevated Lp(a). Reclassification from RF-CL to RF-CLLp(a) improved likelihood stratification in the derivation cohort but not in the validation cohort. Conclusion Adding elevated Lp(a) as a risk factor to the RF-CL model improves accuracy of obstructive CAD in patients with high Lp(a).
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Collaborators (54)
Henrik Birn
VIP, Clinical Professor and Chair
Aarhus Universitet Health
Jelmer Westra
Aarhus University
Marc Gunter
International Agency for Research on Cancer
Holger Thiele
Leipzig University
Morten Schmidt
Aarhus University
Arijit Khan
Associate Professor
Aalborg University
Marie Bodilsen Nielsen
Aarhus University
Dominik C Benz
Group Leader
University of Zurich
Antonio J Quesada
Head of the Clinical Trials Coordination Unit
Centro Nacional de Investigaciones Cardiovasculares (CNIC)
Teemu Maaniitty
-
Frederik Filip Stæger
Københavns Universitet
Archana Kulasingam
Aarhus University
Ana Viñuela
Academic, Lecturer (Teaching and Research)
University of Dundee
Ewan Pearson
Academic, Clinical Professor (Teaching and Research) of Diabetic Medicine
University of Dundee
Salma Raghad Karim
Aarhus University
Henrik Toft Sørensen
VIP, Professor
Aarhus University
Anne Mohr Drewes
Aarhus University
Diana Gorog
Visiting Professor
Imperial College London
Benedikt Kessler
Professor of Biochemistry and Life Science Mass Spectrometry
University of Oxford
Jingyuan Fu
Full professor
University Medical Center Groningen
Mohsen Ghanbari
Associate professor
Erasmus MC
Klaus Fuglsang Kofoed
Professor
Rigshospitalet
José Javier Fuster
Assistant Professor
Centro Nacional de Investigaciones Cardiovasculares (CNIC)
Maik Pietzner
Professor
Queen Mary University of London
Bjarne L. Nørgaard
-
Pamela Douglas
Duke University
Steffen E Petersen
Professor of Cardiovascular Medicine
Queen Mary University of London
Lars Christian Gormsen
VIP, Clinical Professor and Chair
Aarhus University
Simon Cichosz
Aalborg University
Mette Nyegaard
Head of Department
Aalborg University
Fatima Sanchez-Cabo
Head
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Hanna M. Björck
Karolinska Institutet
Sotirios Nedios
Leipzig University
Palle Duun Rohde
Associate Professor
Aalborg University
Laust Dupont Rasmussen
MD, PhD
Aalborg University Hospital
Kristian Kragholm
Aalborg University
Julia Kraft
Charité - Universitätsmedizin Berlin
Andreas Bugge Tinggaard
VIP, Assistant Professor
Aarhus University
Peter Vedsted
Professor
Aarhus University
Lau Brix
VIP, Associate Professor
Aarhus University
Joachim Weber
Head of Strategic Science Management
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Ronny Ralf Buechel
University Hospital of Zurich
Morten Bøttcher
VIP, Clinical Professor
Aarhus University
Christiaan Vrints
Antwerp University Hospital
Jonathan Nørtoft Dahl
Aarhus University
Kasper Bonnesen
Aarhus University
Evald Høj Christiansen
-
Jemma Hopewell
Professor of Precision Medicine & Epidemiology
University of Oxford
Hanne Mari Skou Jørgensen
Associate Professor
Aarhus University
Juhani Knuuti
-
Samuel Emil Schmidt
Aalborg University
A. Zhernakova
Scientific Staff
University Medical Center Groningen
Morten Hasselstrøm Jensen
Aalborg University
Lars Poulsen Tolbod
Associate Professor
Aarhus University
Make your next move.
Prepare your application
Review drafts before you send them.